Föreläsningar och seminarier OnkPat Friday Seminar: T Cell Receptor Gene Modified T Cells for the Immunotherapy of Cancer
2025-11-14 12:30 Lägg till i iCal
Karolinska Universitetssjukhuset, Solna J3:13 Marc Bygdeman, BioClinicum
Välkommen till OnkPat Friday Seminar med Michael Nishimura, professor vid Loyola University Chicago.
Värd: Stina Wickström, institutionen för onkologi-patologi
Relaterade publikationer
Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior.
Wang SY, Scurti GM, Dalheim AV, Quinn S, Stiff PJ, Nishimura MI
Blood Adv 2024 Jan;8(2):324-335
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus.
Barisic S, Brahmbhatt EM, Cherkasova E, Spear TT, Savani U, Pierre S, Scurti GM, Chen L, Igboko M, Nadal R, Zeng G, Parry G, Stroncek DF, Highfill S, Dalheim AV, Reger R, Nishimura MI, Childs RW
J Immunother Cancer 2024 Sep;12(9):